Supervised machine learning to validate a novel scoring system for the prediction of disease remission of functional pituitary adenomas following transsphenoidal surgery.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 09 2023
16 09 2023
Historique:
received:
05
06
2023
accepted:
06
09
2023
medline:
18
9
2023
pubmed:
17
9
2023
entrez:
16
9
2023
Statut:
epublish
Résumé
Functional pituitary adenomas (FPAs) are associated with hormonal hypersecretion resulting in systemic endocrinopathies and increased mortality. The heterogenous composition of the FPA population has made modeling predictive factors of postoperative disease remission a challenge. Here, we aim to define a novel scoring system predictive of disease remission following transsphenoidal surgery (TSS) for FPAs and validate our process using supervised machine learning (SML). 392 patients with FPAs treated at one of the three Mayo Clinic campuses were retrospectively reviewed. Variables found significant on multivariate analysis were incorporated into our novel Pit-SCHEME score. The Pit-SCHEME score with a cut-off value ≥ 6 achieved a sensitivity of 86% and positive likelihood ratio of 2.88. In SML models, without the Pit-SCHEME score, the k-nearest neighbor (KNN) model achieved the highest accuracy at 75.6%. An increase in model sensitivity was achieved with inclusion of the Pit-SCHEME score with the linear discriminant analysis (LDA) model achieving an accuracy of 86.9%, which suggests the Pit-SCHEME score is the variable of most importance for prediction of postoperative disease remission. Ultimately, these results support the potential clinical utility of the Pit-SCHEME score and its prospective future for aiding in the perioperative decision making in patients with FPAs.
Identifiants
pubmed: 37717023
doi: 10.1038/s41598-023-42157-3
pii: 10.1038/s41598-023-42157-3
pmc: PMC10505180
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15409Informations de copyright
© 2023. Springer Nature Limited.
Références
Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33, 6–26. https://doi.org/10.1007/s12022-022-09703-7 (2022).
doi: 10.1007/s12022-022-09703-7
pubmed: 35291028
Mehta, G. U. & Lonser, R. R. Management of hormone-secreting pituitary adenomas. Neuro Oncol. 19, 762–773. https://doi.org/10.1093/neuonc/now130 (2017).
doi: 10.1093/neuonc/now130
pubmed: 27543627
Arnaldi, G. et al. Diagnosis and complications of Cushing’s syndrome: A consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602. https://doi.org/10.1210/jc.2003-030871 (2003).
doi: 10.1210/jc.2003-030871
pubmed: 14671138
Tritos, N. A. & Miller, K. K. Diagnosis and management of pituitary adenomas: A review. JAMA 329, 1386–1398. https://doi.org/10.1001/jama.2023.5444 (2023).
doi: 10.1001/jama.2023.5444
pubmed: 37097352
Lonser, R. R., Nieman, L. & Oldfield, E. H. Cushing’s disease: Pathobiology, diagnosis, and management. J. Neurosurg. 126, 404–417. https://doi.org/10.3171/2016.1.Jns152119 (2017).
doi: 10.3171/2016.1.Jns152119
pubmed: 27104844
Hinojosa-Amaya, J. M. & Cuevas-Ramos, D. The definition of remission and recurrence of Cushing’s disease. Best Pract. Res. Clin. Endocrinol. Metab. 35, 101485. https://doi.org/10.1016/j.beem.2021.101485 (2021).
doi: 10.1016/j.beem.2021.101485
pubmed: 33472761
Melmed, S. et al. A consensus statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14, 552–561. https://doi.org/10.1038/s41574-018-0058-5 (2018).
doi: 10.1038/s41574-018-0058-5
pubmed: 30050156
pmcid: 7136157
Lv, L. et al. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: A retrospective study with long-term follow-up. Endocrine 66, 310–318. https://doi.org/10.1007/s12020-019-02029-1 (2019).
doi: 10.1007/s12020-019-02029-1
pubmed: 31368083
Knosp, E., Steiner, E., Kitz, K. & Matula, C. Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610–618 (1993).
pubmed: 8232800
Demšar, J. Statistical comparisons of classifiers over multiple data sets. J. Mach. Learn. Res. 7, 1–30 (2006).
Kuhn, M. Building Predictive Models in R Using the caret Package. J. Stat. Softw. 28, 1–26. https://doi.org/10.18637/jss.v028.i05 (2008).
doi: 10.18637/jss.v028.i05
Hofstetter, C. P. et al. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg. Focus 30, E10. https://doi.org/10.3171/2011.1.Focus10317 (2011).
doi: 10.3171/2011.1.Focus10317
pubmed: 21456921
Dhandapani, S. et al. Cavernous sinus invasion in pituitary adenomas: Systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery. World Neurosurg. 96, 36–46. https://doi.org/10.1016/j.wneu.2016.08.088 (2016).
doi: 10.1016/j.wneu.2016.08.088
pubmed: 27591098
Ishida, A. et al. Resection of the cavernous sinus medial wall improves remission rate in functioning pituitary tumors: Retrospective analysis of 248 consecutive cases. Neurosurgery 91, 775–781. https://doi.org/10.1227/neu.0000000000002109 (2022).
doi: 10.1227/neu.0000000000002109
pubmed: 36001781
Buchy, M. et al. Predicting early post-operative remission in pituitary adenomas: Evaluation of the modified knosp classification. Pituitary 22, 467–475. https://doi.org/10.1007/s11102-019-00976-6 (2019).
doi: 10.1007/s11102-019-00976-6
pubmed: 31286328
Micko, A. S., Wöhrer, A., Wolfsberger, S. & Knosp, E. Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg. 122, 803–811. https://doi.org/10.3171/2014.12.Jns141083 (2015).
doi: 10.3171/2014.12.Jns141083
pubmed: 25658782
Mortini, P., Barzaghi, L. R., Albano, L., Panni, P. & Losa, M. Microsurgical therapy of pituitary adenomas. Endocrine 59, 72–81. https://doi.org/10.1007/s12020-017-1458-3 (2018).
doi: 10.1007/s12020-017-1458-3
pubmed: 29067608
Shahrestani, S. et al. Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas. Pituitary 24, 523–529. https://doi.org/10.1007/s11102-021-01128-5 (2021).
doi: 10.1007/s11102-021-01128-5
pubmed: 33528731
Mohyeldin, A. et al. Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci. Rep. 12, 9919. https://doi.org/10.1038/s41598-022-12980-1 (2022).
doi: 10.1038/s41598-022-12980-1
pubmed: 35705579
pmcid: 9200976
Han, Y.-L. et al. Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery. Medicine 97, e13198. https://doi.org/10.1097/md.0000000000013198 (2018).
doi: 10.1097/md.0000000000013198
pubmed: 30407358
pmcid: 6250442
Roelfsema, F., Biermasz, N. R. & Pereira, A. M. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: A structured review and meta-analysis. Pituitary 15, 71–83. https://doi.org/10.1007/s11102-011-0347-7 (2012).
doi: 10.1007/s11102-011-0347-7
pubmed: 21918830
Chen, C. et al. Incidence, demographics, and survival of patients with primary pituitary tumors: A SEER database study in 2004–2016. Sci. Rep. 11, 15155. https://doi.org/10.1038/s41598-021-94658-8 (2021).
doi: 10.1038/s41598-021-94658-8
pubmed: 34312470
pmcid: 8313564
Yoo, F., Chan, C., Kuan, E. C., Bergsneider, M. & Wang, M. B. Comparison of male and female prolactinoma patients requiring surgical intervention. J. Neurol. Surg. B Skull Base 79, 394–400. https://doi.org/10.1055/s-0037-1615748 (2018).
doi: 10.1055/s-0037-1615748
pubmed: 30009121
Liu, W. et al. Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: A retrospective single center study. Pituitary 21, 454–462. https://doi.org/10.1007/s11102-018-0898-y (2018).
doi: 10.1007/s11102-018-0898-y
pubmed: 29936681
Akin, S. et al. Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases. Acta Neurochir. 158, 933–942. https://doi.org/10.1007/s00701-016-2762-z (2016).
doi: 10.1007/s00701-016-2762-z
pubmed: 26970763
Colao, A. et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur. J. Endocrinol. 148, 325–331. https://doi.org/10.1530/eje.0.1480325 (2003).
doi: 10.1530/eje.0.1480325
pubmed: 12611613
Delgrange, E., Trouillas, J., Maiter, D., Donckier, J. & Tourniaire, J. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J. Clin. Endocrinol. Metab. 82, 2102–2107. https://doi.org/10.1210/jcem.82.7.4088 (1997).
doi: 10.1210/jcem.82.7.4088
pubmed: 9215279
Fainstein-Day, P. et al. Gender differences in macroprolactinomas: Study of clinical features, outcome of patients and ki-67 expression in tumor tissue. Front. Horm. Res. 38, 50–58. https://doi.org/10.1159/000318494 (2010).
doi: 10.1159/000318494
pubmed: 20616495
Abellán-Galiana, P. et al. Prognostic usefulness of ACTH in the postoperative period of Cushing’s disease. Endocr. Connect. 8, 1262–1272. https://doi.org/10.1530/ec-19-0297 (2019).
doi: 10.1530/ec-19-0297
pubmed: 31394502
pmcid: 6733365
Nieman, L. K. et al. Treatment of cushing’s syndrome: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 2807–2831. https://doi.org/10.1210/jc.2015-1818 (2015).
doi: 10.1210/jc.2015-1818
pubmed: 26222757
pmcid: 4525003
Esposito, F. et al. Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for cushing’s disease. J. Clin. Endocrinol. Metab. 91, 7–13. https://doi.org/10.1210/jc.2005-1204 (2006).
doi: 10.1210/jc.2005-1204
pubmed: 16234305
Acebes, J., Martino, J., Masuet, C., Montanya, E. & Soler, J. Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease. Acta Neurochirurg. 2007, 471–477 (2007).
doi: 10.1007/s00701-007-1133-1
Valassi, E. et al. Delayed remission after transsphenoidal surgery in patients with cushing’s disease. J. Clin. Endocrinol. Metab. 95, 601–610. https://doi.org/10.1210/jc.2009-1672 (2010).
doi: 10.1210/jc.2009-1672
pubmed: 20080848
pmcid: 2840864
Dai, C. et al. Development and interpretation of multiple machine learning models for predicting postoperative delayed remission of acromegaly patients during long-term follow-up. Front. Endocrinol. 11, 859. https://doi.org/10.3389/fendo.2020.00643 (2020).
doi: 10.3389/fendo.2020.00643
Kim, E. H., Oh, M. C., Lee, E. J. & Kim, S. H. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery 70, 1106–1113. https://doi.org/10.1227/NEU.0b013e31823f5c16 (2012).
doi: 10.1227/NEU.0b013e31823f5c16
pubmed: 22067418
Dehghani, M. et al. Association of different pathologic subtypes of growth hormone producing pituitary adenoma and remission in acromegaly patients: A retrospective cohort study. BMC Endocr. Disord. 21, 186. https://doi.org/10.1186/s12902-021-00850-2 (2021).
doi: 10.1186/s12902-021-00850-2
pubmed: 34530798
pmcid: 8447747
Feelders, R. A. et al. Postoperative evaluation of patients with acromegaly: Clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J. Clin. Endocrinol. Metab. 90, 6480–6489. https://doi.org/10.1210/jc.2005-0901 (2005).
doi: 10.1210/jc.2005-0901
pubmed: 16159936
Shen, M. et al. Surgical results and predictors of initial and delayed remission for growth hormone-secreting pituitary adenomas using the 2010 consensus criteria in 162 patients from a single center. World Neurosurg. https://doi.org/10.1016/j.wneu.2018.11.179 (2018).
doi: 10.1016/j.wneu.2018.11.179
pubmed: 31108079
Wright, K. et al. Determinants of surgical remission in prolactinomas: A systematic review and meta-analysis. World Neurosurg. 154, e349–e369. https://doi.org/10.1016/j.wneu.2021.07.035 (2021).
doi: 10.1016/j.wneu.2021.07.035
pubmed: 34325023
Amar, A. P., Couldwell, W. T., Chen, J. C. T. & Weiss, M. H. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J. Neurosurg. 97, 307–314. https://doi.org/10.3171/jns.2002.97.2.0307 (2002).
doi: 10.3171/jns.2002.97.2.0307
pubmed: 12186458
Hespanhol, L., Vallio, C. S., Costa, L. M. & Saragiotto, B. T. Understanding and interpreting confidence and credible intervals around effect estimates. Braz. J. Phys. Ther. 23, 290–301. https://doi.org/10.1016/j.bjpt.2018.12.006 (2019).
doi: 10.1016/j.bjpt.2018.12.006
pubmed: 30638956